Abstract
Human amniotic fluid has been used in prenatal diagnosis for more than 70 years. It has proven to be a safe, reliable, and simple screening tool for a wide variety of developmental and genetic diseases. However, there is now evidence that amniotic fluid may be more than just a diagnostic tool – it may be the source of a powerful therapy for a multitude of congenital and adult disorders. A subset of cells found in the amniotic fluid and placenta appears to be capable of maintaining prolonged undifferentiated proliferation. In addition, these cells can also differentiate into multiple tissue types that encompass the three embryonic germ layers of the embryo, suggesting that they could be used for a myriad of tissue engineering and cell therapeutic applications. It is possible that in the near future, we will see the development of therapies that use progenitor cells isolated from amniotic fluid and placenta for the treatment of newborns with congenital malformations as well as the development of therapies for adults that make use of cryopreserved amniotic fluid and placental stem cells. Here, we describe the isolation and characterization of pluripotent progenitor cells from amniotic fluid and placenta and the various cell lines derived from these cells. Finally, we discuss the potential future directions for this research.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Snow MH, Bennett D. Gastrulation in the mouse: assessment of cell populations in the epiblast of tw18/tw18 embryos. J Embryol Exp Morphol. 1978;47:39-52.
Downs KM, Harmann C. Developmental potency of the murine allantois. Development. 1997;124(14):2769-2780.
Downs KM, Hellman ER, McHugh J, Barrickman K, Inman KE. Investigation into a role for the primitive streak in development of the murine allantois. Development. 2004;131(1):37-55.
Gardner RL, Beddington RS. Multi-lineage ‘stem’ cells in the mammalian embryo. J Cell Sci. 1988;10(suppl):11-27.
Loebel DA, Watson CM, De Young RA, Tam PP. Lineage choice and differentiation in mouse embryos and embryonic stem cells. Dev Biol. 2003;264(1):1-14.
Moser M, Li Y, Vaupel K, et al. Placental failure and impaired vasculogenesis result in embryonic lethality for neuropathy target esterase-deficient mice. Mol Cell Biol. 2004;24(4):1667-1679.
Smith JL, Gesteland KM, Schoenwolf GC. Prospective fate map of the mouse primitive streak at 7.5 days of gestation. Dev Dyn. 1994;201(3):279-289.
Kinder SJ, Tsang TE, Quinlan GA, Hadjantonakis AK, Nagy A, Tam PP. The orderly allocation of mesodermal cells to the extraembryonic structures and the anteroposterior axis during gastrulation of the mouse embryo. Development. 1999;126(21):4691-4701.
Parameswaran M, Tam PP. Regionalisation of cell fate and morphogenetic movement of the mesoderm during mouse gastrulation. Dev Genet. 1995;17(1):16-28.
Rathjen J, Lake JA, Bettess MD, Washington JM, Chapman G, Rathjen PD. Formation of a primitive ectoderm like cell population, EPL cells, from ES cells in response to biologically derived factors. J Cell Sci. 1999;112(Pt 5):601-612.
Dang SM, Kyba M, Perlingeiro R, Daley GQ, Zandstra PW. Efficiency of embryoid body formation and hematopoietic development from embryonic stem cells in different culture systems. Biotechnol Bioeng. 2002;78(4):442-453.
Li L, Arman E, Ekblom P, Edgar D, Murray P, Lonai P. Distinct GATA6- and laminin-dependent mechanisms regulate endodermal and ectodermal embryonic stem cell fates. Development. 2004;131(21):5277-5286.
Kaviani A, Perry TE, Dzakovic A, Jennings RW, Ziegler MM, Fauza DO. The amniotic fluid as a source of cells for fetal tissue engineering. J Pediatr Surg. 2001;36(11):1662-1665.
Robinson WP, McFadden DE, Barrett IJ, et al. Origin of amnion and implications for evaluation of the fetal genotype in cases of mosaicism. Prenat Diagn. 2002;22(12):1076-1085.
Bartha JL, Romero-Carmona R, Comino-Delgado R, Arce F, Arrabal J. Alpha-fetoprotein and hematopoietic growth factors in amniotic fluid. Obstet Gynecol. 2000;96(4):588-592.
Heidari Z, Isobe K, Goto S, Nakashima I, Kiuchi K, Tomoda Y. Characterization of the growth factor activity of amniotic fluid on cells from hematopoietic and lymphoid organs of different life stages. Microbiol Immunol. 1996;40(8):583-589.
Sakuragawa N, Elwan MA, Fujii T, Kawashima K. Possible dynamic neurotransmitter metabolism surrounding the fetus. J Child Neurol. 1999;14(4):265-266.
Srivastava MD, Lippes J, Srivastava BI. Cytokines of the human reproductive tract. Am J Reprod Immunol. 1996;36(3):157-166.
Baschat AA, Hecher K. Fetal growth restriction due to placental disease. Semin Perinatol. 2004;28(1):67-80.
Prusa AR, Hengstschlager M. Amniotic fluid cells and human stem cell research: a new connection. Med Sci Monitor. 2002;8(11):RA253-RA257.
Medina-Gomez P, del Valle M. Cultivo de celas de liquido amniotico. Analisis de colonias, metafases e indice mitotico, con fin de descartar contaminacion de celulas maternas. Gynecol Obstet Mex. 1988;56:122-126.
In ‘t Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood. 2003;102(4):1548-1549.
Prusa AR, Marton E, Rosner M, et al. Neurogenic cells in human amniotic fluid. Am J Obstet Gynecol. 2004;191(1):309-314.
De Coppi P, Bartsch G Jr, Siddiqui MM, et al. Isolation of amniotic stem cell lines with potential for therapy.[see comment]. Nat Biotechnol. 2007;25(1):100-106.
Siddiqui MJ, Atala A. Aminiotic fluid derived pluripotential cells. In: Handbook of Stem Cells. San Diego, CA: Elsevier Academic Press; 2004:175-179.
Bryan TM, Englezou A, Dunham MA, Reddel RR. Telomere length dynamics in telomerase-positive immortal human cell populations. Exp Cell Res. 1998;239(2):370-378.
Cremer M, Schachner M, Cremer T, Schmidt W, Voigtlander T. Demonstration of astrocytes in cultured amniotic fluid cells of three cases with neural-tube defect. Hum Genet. 1981;56(3):365-370.
Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem. 1997;64(2):295-312.
Karsenty G. Role of Cbfa1 in osteoblast differentiation and function. Semin Cell Dev Biol. 2000;11(5):343-346.
Komori T, Yagi H, Nomura S, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts [see comment]. Cell. 1997;89(5):755-764.
Delo DM, De Coppi P, Bartsch G Jr, Atala A. Amniotic fluid and placental stem cells. Method Enzymol. 2006;419:426-438.
Dunn JC, Yarmush ML, Koebe HG, Tompkins RG. Hepatocyte function and extracellular matrix geometry: long-term culture in a sandwich configuration. FASEB J. 1989;3(2):174-177 [erratum appears in FASEB J May 1989;3(7):1873].
Schwartz RE, Reyes M, Koodie L, et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest. 2002;109(10):1291-1302.
Hamazaki T, Iiboshi Y, Oka M, et al. Hepatic maturation in differentiating embryonic stem cells in vitro. FEBS Lett. 2001;497(1):15-19.
Rosenblatt JD, Lunt AI, Parry DJ, Partridge TA. Culturing satellite cells from living single muscle fiber explants. In Vitro Cell Dev Biol Anim. 1995;31(10):773-779.
Bailey P, Holowacz T, Lassar AB. The origin of skeletal muscle stem cells in the embryo and the adult. Curr Opin Cell Biol. 2001;13(6):679-689.
Rohwedel J, Maltsev V, Bober E, Arnold HH, Hescheler J, Wobus AM. Muscle cell differentiation of embryonic stem cells reflects myogenesis in vivo: developmentally regulated expression of myogenic determination genes and functional expression of ionic currents. Dev Biol. 1994;164(1):87-101.
Hinterberger TJ, Sassoon DA, Rhodes SJ, Konieczny SF. Expression of the muscle regulatory factor MRF4 during somite and skeletal myofiber development. Dev Biol. 1991;147(1):144-156.
Patapoutian A, Yoon JK, Miner JH, Wang S, Stark K, Wold B. Disruption of the mouse MRF4 gene identifies multiple waves of myogenesis in the myotome. Development. 1995;121(10):3347-3358.
Black IB, Woodbury D. Adult rat and human bone marrow stromal stem cells differentiate into neurons. Blood Cell Mol Dis. 2001;27(3):632-636.
Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res. 2000;61(4):364-370.
Guan K, Chang H, Rolletschek A, Wobus AM. Embryonic stem cell-derived neurogenesis. Retinoic acid induction and lineage selection of neuronal cells. Cell Tissue Res. 2001;305(2):171-176.
Carpenter MK, Inokuma MS, Denham J, Mujtaba T, Chiu CP, Rao MS. Enrichment of neurons and neural precursors from human embryonic stem cells. Exp Neurol. 2001;172(2):383-397.
Chazan JA, Libbey NP, London MR, Pono L, Abuelo JG. The clinical spectrum of renal osteodystrophy in 57 chronic hemodialysis patients: a correlation between biochemical parameters and bone pathology findings. Clin Nephrol. 1991;35(2):78-85.
Cohen J, Hopkin J, Kurtz J. Infectious Complications After Renal Transplantation. Philadelphia, PA: W.B. Saunders; 1994.
Ojo AO, Hanson JA, Wolfe RA, Leichtman AB, Agodoa LY, Port FK. Long-term survival in renal transplant recipients with graft function. Kidney Int. 2000;57(1):307-313.
Ojo AO, Hanson JA, Meier-Kriesche H, et al. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol. 2001;12(3):589-597.
Perin L, Giuliani S, Jin D, et al. Renal differentiation of amniotic fluid stem cells. Cell Prolif. 2007;40(6):936-948.
De Coppi P, Bartsch G Jr, Siddiqui MM, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol. 2007;25(1):100-106.
Hoehn H, Bryant EM, Fantel AG, Martin GM. Cultivated cells from diagnostic amniocentesis in second trimester pregnancies. III. The fetal urine as a potential source of clonable cells. Humangenetik. 1975;29(4):285-290.
In ‘t Anker PS, Scherjon SA, Kleijburg-van der Keur C, et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation 3. Blood. 2003; 102(4):1548-1549.
Tsai MS, Lee JL, Chang YJ, Hwang SM. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol 2. Hum Reprod. 2004;19(6):1450-1456.
Acknowledgment
The author wishes to thank Dr. Jennifer Olson for editorial assistance with this manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer London
About this chapter
Cite this chapter
Atala, A. (2011). Amniotic Fluid and Placenta Stem Cells. In: Bhattacharya, N., Stubblefield, P. (eds) Regenerative Medicine Using Pregnancy-Specific Biological Substances. Springer, London. https://doi.org/10.1007/978-1-84882-718-9_36
Download citation
DOI: https://doi.org/10.1007/978-1-84882-718-9_36
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-84882-717-2
Online ISBN: 978-1-84882-718-9
eBook Packages: MedicineMedicine (R0)